Gillian M. Blue

2.3k total citations
29 papers, 806 citations indexed

About

Gillian M. Blue is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gillian M. Blue has authored 29 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 22 papers in Epidemiology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gillian M. Blue's work include Congenital Heart Disease Studies (22 papers), Congenital heart defects research (19 papers) and Genomics and Rare Diseases (4 papers). Gillian M. Blue is often cited by papers focused on Congenital Heart Disease Studies (22 papers), Congenital heart defects research (19 papers) and Genomics and Rare Diseases (4 papers). Gillian M. Blue collaborates with scholars based in Australia, United States and Iran. Gillian M. Blue's co-authors include David S. Winlaw, Gary F. Sholler, Richard P. Harvey, Edwin P. Kirk, Sally L. Dunwoodie, Eleni Giannoulatou, Nadine A. Kasparian, Alexis Bosman, Joshua W. K. Ho and Andrew D. Cole and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and BMC Bioinformatics.

In The Last Decade

Gillian M. Blue

24 papers receiving 798 citations

Peers

Gillian M. Blue
Dan Taylor United Kingdom
Jason Cowan United States
Thomas Krebs Germany
Lindsay T. McDonald United States
Jelte de Haan Netherlands
Gillian M. Blue
Citations per year, relative to Gillian M. Blue Gillian M. Blue (= 1×) peers Lisa Leth Maroun

Countries citing papers authored by Gillian M. Blue

Since Specialization
Citations

This map shows the geographic impact of Gillian M. Blue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian M. Blue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian M. Blue more than expected).

Fields of papers citing papers by Gillian M. Blue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian M. Blue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian M. Blue. The network helps show where Gillian M. Blue may publish in the future.

Co-authorship network of co-authors of Gillian M. Blue

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian M. Blue. A scholar is included among the top collaborators of Gillian M. Blue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian M. Blue. Gillian M. Blue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thibaut, L, Debjani Das, David S. Winlaw, et al.. (2024). Benchmarking of variant pathogenicity prediction methods using a population genetics approach. Bioinformatics Advances. 5(1). vbaf227–vbaf227.
2.
Cole, Andrew D., Richard P. Harvey, Sally L. Dunwoodie, et al.. (2024). The Kids Heart BioBank: supporting 20 years of patient care and research into CHD. Cardiology in the Young. 34(8). 1645–1652.
3.
Thibaut, L, Matloob Khushi, Gillian M. Blue, et al.. (2023). ConanVarvar: a versatile tool for the detection of large syndromic copy number variation from whole-genome sequencing data. BMC Bioinformatics. 24(1). 49–49. 1 indexed citations
4.
Verrall, Charlotte E., Shrujna Patel, Jason Tchieu, et al.. (2023). Biological and structural phenotypes associated with neurodevelopmental outcomes in congenital heart disease. Translational Pediatrics. 12(4). 768–786. 9 indexed citations
5.
Lain, Samantha J., Gillian M. Blue, David S. Winlaw, et al.. (2023). Using novel data linkage of biobank data with administrative health data to inform genomic analysis for future precision medicine treatment of congenital heart disease. International Journal for Population Data Science. 8(1). 2150–2150. 1 indexed citations
6.
Smith, Janine, Annabelle Enriquez, Gary F. Sholler, et al.. (2021). A new era of genetic testing in congenital heart disease: A review. Trends in Cardiovascular Medicine. 32(5). 311–319. 7 indexed citations
7.
Blue, Gillian M., Debjani Das, Michael Troup, et al.. (2021). Whole genome sequencing in transposition of the great arteries and associations with clinically relevant heart, brain and laterality genes. American Heart Journal. 244. 1–13. 12 indexed citations
8.
Verrall, Charlotte E., et al.. (2020). “Why and how did this happen?”: development and evaluation of an information resource for parents of children with CHD. Cardiology in the Young. 30(3). 346–352. 4 indexed citations
9.
Blue, Gillian M., Janine Smith, Gary F. Sholler, Christopher Semsarian, & David S. Winlaw. (2020). Current Practice of Genetic Testing and Counselling in Congenital Heart Disease: An Australian Perspective. Heart Lung and Circulation. 29(11). 1733–1736.
10.
Sabbaghian, Nelly, M. Cristina Digilio, Gillian M. Blue, et al.. (2018). Analysis of DICER1 in familial and sporadic cases of transposition of the great arteries. Congenital Heart Disease. 13(3). 401–406. 2 indexed citations
11.
Blue, Gillian M., Eddie Ip, Karen Walker, et al.. (2018). Genetic burden and associations with adverse neurodevelopment in neonates with congenital heart disease. American Heart Journal. 201. 33–39. 20 indexed citations
12.
Blue, Gillian M., Edwin P. Kirk, Eleni Giannoulatou, et al.. (2017). Advances in the Genetics of Congenital Heart Disease. Journal of the American College of Cardiology. 69(7). 859–870. 106 indexed citations
13.
Blue, Gillian M., David T. Humphreys, Justin O. Szot, et al.. (2016). The promises and challenges of exome sequencing in familial, non-syndromic congenital heart disease. International Journal of Cardiology. 230. 155–163. 9 indexed citations
14.
Blue, Gillian M. & David S. Winlaw. (2015). Next Generation Sequencing in Congenital Heart Disease: Gene Discovery and Clinical Application. 2(1). 1 indexed citations
15.
Blue, Gillian M., Nadine A. Kasparian, Gary F. Sholler, Edwin P. Kirk, & David S. Winlaw. (2014). Genetic counselling in parents of children with congenital heart disease significantly improves knowledge about causation and enhances psychosocial functioning. International Journal of Cardiology. 178. 124–130. 27 indexed citations
16.
Blue, Gillian M., Edwin P. Kirk, Eleni Giannoulatou, et al.. (2014). Targeted Next-Generation Sequencing Identifies Pathogenic Variants in Familial Congenital Heart Disease. Journal of the American College of Cardiology. 64(23). 2498–2506. 63 indexed citations
17.
Marjaneh, Mahdi Moradi, Edwin P. Kirk, Maximilian Posch, et al.. (2011). Investigation of Association between PFO Complicated by Cryptogenic Stroke and a Common Variant of the Cardiac Transcription Factor GATA4. PLoS ONE. 6(6). e20711–e20711. 4 indexed citations
18.
Esposito, Giorgia, Tanya L. Butler, Gillian M. Blue, et al.. (2011). Somatic mutations in NKX2–5, GATA4, and HAND1 are not a common cause of tetralogy of Fallot or hypoplastic left heart. American Journal of Medical Genetics Part A. 155(10). 2416–2421. 26 indexed citations
19.
Butler, Tanya L., Giorgia Esposito, Gillian M. Blue, et al.. (2010). GATA4 Mutations in 357 Unrelated Patients with Congenital Heart Malformation. Genetic Testing and Molecular Biomarkers. 14(6). 797–802. 48 indexed citations
20.
Blue, Gillian M., Andrew D. Cole, Meredith Wilson, et al.. (2007). The negative impact of Alagille syndrome on survival of infants with pulmonary atresia. Journal of Thoracic and Cardiovascular Surgery. 133(4). 1094–1096. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026